Shandong Sinoglory Health (603182) — Capital Reinvestment Ratio
Shandong Sinoglory Health (603182) has a Capital Reinvestment Ratio of 0.69x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥79.36 Million) in capital expenditures (CN¥54.75 Million). Check 603182 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Sinoglory Health Capital Reinvestment Ratio (2020–2025)
This chart tracks Shandong Sinoglory Health's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Shandong Sinoglory Health cash flow conversion.
Annual Capital Reinvestment Ratio for Shandong Sinoglory Health (2020–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Sinoglory Health from 2020 to 2025. See 603182 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | CN¥79.36 Million | CN¥54.75 Million | ▼ -45.8% |
| 2024 | 1.27x | CN¥313.81 Million | CN¥399.54 Million | ▼ -69.3% |
| 2023 | 4.15x | CN¥37.34 Million | CN¥154.79 Million | ▲ +899.3% |
| 2022 | 0.41x | CN¥109.17 Million | CN¥45.29 Million | ▼ -46.6% |
| 2021 | 0.78x | CN¥43.34 Million | CN¥33.70 Million | ▲ +20.0% |
| 2020 | 0.65x | CN¥109.73 Million | CN¥71.10 Million | — |